Where the CRISPR Patent Dispute Stands in October 2026: Broad Leads, but Nothing Is Final
On March 26, 2026 the PTAB again awarded the Broad Institute priority for CRISPR-Cas9 in eukaryotic cells. The ruling is narrower than headlines suggest, and…
Patent Disputes